Sci Forschen
O p e n HUB for Sc i e n t i f i c R e s e a r c h
Citaon: Chakraborty AK (2022) Hyper-Variable Spike Protein of Omicron Corona Virus and Its Dierences with Alpha and Delta
Variants: Prospects of RT-PCR and New Vaccine. J Emerg Dis Virol 7(1): dx.doi.org/10.16966/2473-1846.166
12
Journal of Emerging Diseases and Virology
Open Access Journal
Question arises such hyper-variable dierence of omicron spike
protein could be involved in the vaccine failure for the corona vaccine
made from S gene! Analysis suggested that some hydrophobic regions
had similarity and surely partial protection possible! Study indicated
that only 20% and 24% of BNT162b2 vaccine recipients had detectable
neutralizing antibody against the omicron variant HKU691 and
HKU344-R346K, respectively, while none of the Coronavac recipients
had detectable neutralizing antibody titre against either omicron
isolate. Omicron variant escapes neutralizing antibodies elicited
by BNT162b2 or Coronavac [27]. Using animal model Starr TN, et
al., [28] showed that the antibodies, S2H97 and S2E12 bound with
high anity across all sarbecovirus clades to a cryptic epitope and
prophylactically protects hamsters from viral challenge [28]. Further
study suggested that E484K mutation evaded antibody neutralization
elicited by infection or vaccination and further enhanced by K417N
and N501Y mutations [29]. A very similar conclusion was conrmed
by antibodies raised against deletion mutants of RBD domain of spike
protein [30]. Wang R, et al., [20,21] and others (2021) showed that
the South African variant B.1.351 was the most resistant to current
monoclonal antibodies and convalescent plasma from Wuhan virus
infected individuals, followed by United Kingdom alpha variant
(B.1.1.7) and the Brazilian gamma variant (P.1) with Y144del and
242-244del mutations and important D614G and N501Y mutations as
well as K417N/T, E484K/Q mutations in the RBD domain of the spike
protein of SARS-CoV-2 [27,31,32] (Wand, et al., 2021). Another study
indicated that neutralizing antibodies elicited by inactivated corona
virus vaccine and RBD-subunit spike protein vaccine against B.1.617
and B.1.1.7 variants enhanced viral entry and membrane fusion, as
well as more resistant to antibody neutralization [33-35]. us, all
natural mutations have allosteric eects that drive either interspecies
transmission or escape from antibody neutralization [36]. Omicron
virus was already transmitted in 90 countries and likely will be threat
to humanity [37]. Omicron may be ten times more contagious than
the original virus and twice more infectious than delta variant. We
have shown that omicron viruses are greatly aected many US States
including CA, NY, CO, MN and NJ. Further, omicron may be twice
more likely to escape current vaccines than the delta variant [38].
Wang R, et al., identied fast-growing RBD mutations like N439K,
S477N, S477R, and N501T that enhanced the RBD and ACE2 binding.
L452R mutation in the spike reduces its interaction with Wuhan
corona virus antibodies. Similarly, mutations E484K and K417N
found in South Africa and L452R and E484Q found in India variants
could be responsible for such reduced antibody interaction [21].
Miller NL, et al., preprint disclosed that the omicron variant increased
antibody escape due to mutations in class 3 and 4 antibody epitopes in
the spike protein as well as enhanced transmissibility via disruption of
ligand-receptor interface [26]. Finally, molecular biology of omicron
virus has just started to dene its functions of genetic changes [25].
Although mild symptoms of fever, cold and pneumonia reported,
delmicron (Delta + Omicron) has created a havoc calamity in the
world [39]. Remdesivir drug however has some benet to control
corona virus spread targeting RNA dependent RNA polymerase as
well as some immune drug were discovered [40]. We have pinpointed
the dierences in the spike protein of omicron but omicron spike
protein appeared very stable to interact with ACE-2 receptor. But
genomic mutations may aect RT-PCR (Figure 11) and thus new RT-
PCR primers were presented from conserved regions. Interestingly,
now more sequences for omicron virus will be available in the NCBI
SARS-CoV-2 Database.
Acknowledgement
e work was not funded by any agency. e author thanks CDC
and NCBI for the data provided. AKC is a retired professor.
References
1. Jenkins GM, Rambaut A, Pybus OG, Holmes EC (2002) Rates of
molecular evoluon in RNA viruses: a quantave phylogenec
analysis. J Mol Evol 54: 156-165.
2. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, et al. (2003)
Characterizaon of a novel coronavirus associated with severe acute
respiratory syndrome. Science 300: 1394-1399.
3. Lu G, Wang Q, Gao GF (2015) Bat-to-human: spike features
determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and
beyond. Trends Microbiol 23: 468-478.
4. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, et al. (2013) Isolaon and
characterizaon of a bat SARS-like coronavirus that uses the ACE2
receptor. Nature 503: 535-538.
5. Wu F, Zhao S, Yu B, Chen Y, Wang W, et al. (2020) Complete genome
characterisaon of a novel coronavirus associated with severe
human respiratory disease in Wuhan, China. bioRxiv.
6. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, et al. (2020) Structure of the
RNA-dependent RNA polymerase from COVID-19 virus. Science 368:
779-782.
7. Rut W, Lv Z, Zmudzinski M, Patche S, Nayak D, et al. (2020) Acvity
proling and crystal structures of inhibitor-bound SARS-CoV-2
papain-like protease: A framework for an-COVID-19 drug design.
Sci Adv 6: eabd4596.
8. Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Lima GMA,
et al. (2021) A Crystallographic Snapshot of SARS-CoV-2 Main
Protease Maturaon Process. J Mol Biol 433: 167118.
9. Chakraborty AK (2020) Coronavirus Nsp2 Protein Homologies to the
Bacterial DNA Topoisomerase I and IV Suggest Nsp2 Protein is an
Unique RNA Topoisomerase with Novel Target for Drug and Vaccine
Development. Virol Mycol 9: 185.
10. Chakraborty AK (2020) Coronavirus ORF1ab Polyprotein Associated
Nsp16 Protein is a RlmE Methyltransferase and May Methylate
21S Mitochondrial rRNA of Host Cells Inhibing Protein Synthesis.
Preprints 2020040213.
11. Kim Y, Jedrzejczak R, Maltseva NI, Wilamowski M, Endres M, et al.
(2020) Crystal structure of Nsp15 endoribonuclease NendoU from
SARS-CoV-2. Protein Sci 29: 1596-1605.
12. Chakraborty AK (2020) Mul-Alignment Comparison of Coronavirus
Non-Structural Proteins Nsp13-16 with Ribosomal proteins and
other DNA/RNA modifying Enzymes Suggested Their Roles in the
Regulaon of Host Protein Synthesis. Internaonal J Clini Med
Informacs 3: 7-19.
13. Lu R, Zhao X, Li J, Niu P, Yang B, et al. (2020) Genomic characterisaon
and epidemiology of 2019 novel coronavirus: Implicaons for virus
origins and receptor binding. Lancet 395: 565-574.
14. Homann M, Kleine-Weber H, Pohlmann S (2020) A Mulbasic
cleavage site in the Spike protein of SARS-CoV-2 is essenal for
infecon of human lung cells. Mol Cell 78: 779-784.e5.
15. Li Q, Nie J, Wu J, Zhang L, Ding R, et al. (2021) SARS-CoV-2 501Y.V2
variants lack higher infecvity but do have immune escape. Cell 184:
2362-2371.